Capula Management Ltd
- SEC CIK
- 0001557017
- Latest filing
- Aug 14, 2026
LGND holding history
Ligand Pharmaceuticals Inc in every 13F filed by Capula Management Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −14,900−100.0% | Sold out | Holders |
| Q3 2023 | 14,900 | $892.8K | 0.1% | +7,080+90.5% | Added | Holders |
| Q2 2023 | 7,820 | $563.8K | 0.1% | +7,820 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −11,640−100.0% | Sold out | Holders |
| Q4 2022 | 11,640 | $777.6K | 0.1% | +11,640 | New | Holders |